Amrutanjan Health Care Limited (BOM:590006)

Amrutanjan Health Care Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	112.72	101.55	37.12	49.03	21.86
Short-Term Investments	-	1,561	1,851	2,035	1,724	1,940
Trading Asset Securities	-	30.74	-	0.01	51.47	48.49
Cash & Short-Term Investments	1,787	1,705	1,953	2,072	1,825	2,011
Cash Growth	-10.33%	-12.71%	-5.74%	13.54%	-9.26%	14.68%
Accounts Receivable	-	606.44	558.22	478.89	330.2	382.56
Other Receivables	-	-	-	-	60.83	-
Receivables	-	606.44	558.22	478.89	391.03	382.56
Inventory	-	373.5	272.6	289.05	288.25	260.01
Prepaid Expenses	-	19.16	10.61	8.05	3.59	3.59
Other Current Assets	-	212.72	112.53	109.18	91.97	89.55
Total Current Assets	-	2,916	2,907	2,957	2,599	2,746
Property, Plant & Equipment	-	1,553	639.26	495.44	475.45	434.7
Long-Term Investments	-	462.38	416.98	117.81	426.5	223.09
Other Intangible Assets	-	16.85	17.28	23.78	24.84	23.19
Long-Term Deferred Tax Assets	-	53.15	31.12	31.72	42.54	36.42
Other Long-Term Assets	-	87.21	202.54	43.15	52.12	34.78
Total Assets	-	5,089	4,214	3,669	3,621	3,499

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	708.95	690.43	558.63	474.36	604.49
Accrued Expenses	-	108.94	104.38	92.66	87.63	52.13
Current Portion of Leases	-	3.54	4.02	3.32	5.05	5.69
Current Income Taxes Payable	-	50.73	16.72	16.22	32.54	31.85
Other Current Liabilities	-	389.68	30.29	28.37	30.55	80.57
Total Current Liabilities	-	1,262	845.83	699.19	630.12	774.73
Long-Term Leases	-	14.23	16.76	13.97	4.04	3.11
Pension & Post-Retirement Benefits	-	81.94	66.84	55.94	57.47	47.35
Other Long-Term Liabilities	-	28.56	18.3	14.73	21.58	22.26
Total Liabilities	-	1,387	947.73	783.82	713.21	847.44

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	28.91	28.91	28.91	29.23	29.23
Retained Earnings	-	3,685	3,241	2,873	2,910	2,658
Treasury Stock	-	-8.97	-10.61	-16.18	-44.57	-44.98
Comprehensive Income & Other	-	-2.93	7.33	-0.93	13.21	8.83
Shareholders' Equity	3,702	3,702	3,266	2,885	2,908	2,651
Total Liabilities & Equity	-	5,089	4,214	3,669	3,621	3,499

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	17.77	17.77	20.78	17.28	9.09	8.8
Net Cash (Debt)	1,770	1,687	1,932	2,054	1,816	2,002
Net Cash Growth	-10.29%	-12.69%	-5.96%	13.15%	-9.31%	15.06%
Net Cash Per Share	61.22	58.35	66.83	70.79	62.12	68.47
Filing Date Shares Outstanding	28.91	28.91	28.91	28.91	29.23	29.23
Total Common Shares Outstanding	28.91	28.91	28.91	28.91	29.23	29.23
Working Capital	-	1,655	2,061	2,258	1,969	1,972
Book Value Per Share	128.04	128.06	112.97	99.79	99.48	90.70
Tangible Book Value	3,685	3,685	3,249	2,861	2,883	2,628
Tangible Book Value Per Share	127.46	127.48	112.38	98.96	98.63	89.91
Land	-	22.15	22.15	22.15	23.17	23.17
Buildings	-	243.87	238.1	224.57	220.74	178.65
Machinery	-	550.01	481.56	441.17	439.72	250.81
Construction In Progress	-	1,055	161.98	23.45	11.14	162.65
Leasehold Improvements	-	3.69	3.69	2.53	0.2	0.2

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error